Back to search

Article

Prognostic Nutritional Index (PNI) as a Useful Prognostic Indicator in Patients With HR + HER-2 Negative Metastatic Breast Cancer Treated With CDK 4/6 Inhibitor + Endocrine Therapy

2022-09-28

Abstract excerpt

<h4>Background: </h4> The combination of endocrine therapy and CDK 4/6 inhibitors in the treatment of hormone receptor positive, HER-2 negative metastatic breast cancer resulted in significant increases in survival.In general, the presence of malnutrition in cancer patients is a condition that negatively affects the success of treatment. For this reason, it is important to evaluate the nutritional status of cancer...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d27e9b09-e1d6-5f90-8079-9ad26ea21ef7
DOI
10.21203/rs.3.rs-2079332/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 10 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prognostic Nutritional Index (PNI) as a Useful Prognostic Indicator in Patients With HR + HER-2 Negative Metastatic Breast Cancer Treated With CDK 4/6 Inhibitor + Endocrine TherapyDOI 10.21203/rs.3.rs-2079332/v1
Select a neighboring publication to make it the new centre.